Correction of various abnormalities in cultured porcine von Willebrand endothelial cells by inhibition of plasminogen-dependent protease activity.
D000818:Animals; D001779:Blood Coagulation Factors / Q000235:genetics*; D001792:Blood Platelets; D002448:Cell Adhesion; D002450:Cell Communication; D002478:Cells, Cultured; D004727:Endothelium / Q000032:analysis / Q000201:enzymology; D005337:Fibrin / Q000378:metabolism; D005353:Fibronectins / Q000276:immunology; D006909:Hydroxyproline / Q000096:biosynthesis / Q000378:metabolism; D010447:Peptide Hydrolases / Q000378:metabolism*; D010958:Plasminogen / Q000378:metabolism*; D011392:Proline / Q000378:metabolism; D011480:Protease Inhibitors / Q000494:pharmacology; D013552:Swine; D014841:von Willebrand Factor / Q000235:genetics*
D001779:Blood Coagulation Factors; D005353:Fibronectins; D011480:Protease Inhibitors; D014841:von Willebrand Factor; D005337:Fibrin; D010958:Plasminogen; D011392:Proline; D010447:Peptide Hydrolases; D006909:Hydroxyproline